bisphosphonate-associated osteonecrosis


Also found in: Dictionary.

bis·phos·pho·nate-as·so·ci·a·ted os·te·o·ne·cro·sis

(bis-fosfŏ-nāt ă-sōsē-ā-tĕd ostē-ō-nĕ-krōsis)
Osteonecronecrosis, frequently found in the jaws, associated with prolonged use of bisphosphonates.
References in periodicals archive ?
Which imaging technique should be preferred in bisphosphonate-associated osteonecrosis of the jaw?
Managing the care of patients with bisphosphonate-associated osteonecrosis.
Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research.
Bisphosphonate-associated osteonecrosis of the jaw represents a serious side effect of bisphosphonate administration.
1) Implant surgery on patients receiving bisphosphonate therapy did not result in bisphosphonate-associated osteonecrosis of the jaw.
Last year the American Society for Bone and Mineral Research published a task force report on bisphosphonate-associated osteonecrosis that outlined a case definition so that subsequent studies could report on the same condition (J.
A large case series was published in 2004 when Ruggiero reported that over a 3-year-period (February 2001 to November 2003) his clinic had treated 63 cases of bisphosphonate-associated osteonecrosis of jaw (BON).
The mechanism involved in bisphosphonate-associated osteonecrosis of jaw (BON) is unknown.
The American Academy of Oral Medicine has proposed clinical guidelines for prevention and management of bisphosphonate-associated osteonecrosis of jaw (BON).
Many questions remain concerning the degree of risk for future manifestation of bisphosphonate-associated osteonecrosis of jaw among the huge population who are taking bisphosphonate (BIS) drugs or who have done so in the past.